Seeking Alpha

Dialysis provider DaVita (DVA +5.92%) jumps after the company raises its FY11 guidance and says...

Dialysis provider DaVita (DVA +5.92%) jumps after the company raises its FY11 guidance and says its Q3 looks solid. Q3 EPS is expected to come in between $1.43 - $1.48 per share, well above Street estimates of $1.29, while FY11 revenue should be around $1.13B - $1.16B, up from $1.08B - $1.12B, due to improved treatment volumes and decreasing operating costs.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|